Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 25 September 1998:
Vol. 281. no. 5385, p. 1930
DOI: 10.1126/science.281.5385.1930a
Prev | Table of Contents | Next

News of the Week

BIOMEDICAL POLICY:
Raising the Stakes in the Race for New Malaria Drugs

Jocelyn Kaiser

A group of scientists and funders last week gave an initial thumbs-up to a new strategy for bankrolling what could amount to a $30-million-a-year program to develop drugs against malaria, one of the world's biggest scourges. Although details are still being worked out, drug company representatives and potential donors--who gathered at a closed-door meeting on 17 September at the Rockefeller Foundation in New York City--believe they have overcome key hurdles that undermined a similar effort last November.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)